CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL

Clinical trial NCT06559189 · RECRUITING

Trial details

NCT number: NCT06559189
Sponsor: University of Colorado, Denver
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia

Start date: 2024-09-27
Primary completion: 2028-12-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.